HIKAL LIMITED Financial Ratios
HIKAL · Healthcare · Current price ₹234.76
P/E ratio
-74.9x
P/B ratio
2.3x
ROE
3.0%
ROCE
4.0%
Debt / Equity
0.57
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -74.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 3.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 4.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.57 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with HIKAL LIMITED's latest numbers.
HIKAL LIMITED profitability
HIKAL LIMITED generates a return on equity of 3.0% and a return on capital employed of 4.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.57 and a P/E of -74.9x, HIKAL LIMITED is moderately leveraged. Our overall business-quality score for the company is 3.0 / 10.
Understand the ratios
More on HIKAL LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.